Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.38 - $0.58 $199 - $303
524 Added 3.08%
17,525 $6,000
Q2 2023

Aug 10, 2023

SELL
$0.39 - $0.94 $11,461 - $27,624
-29,388 Reduced 63.35%
17,001 $7,000
Q1 2023

May 11, 2023

SELL
$0.79 - $1.91 $4,780 - $11,557
-6,051 Reduced 11.54%
46,389 $38,000
Q4 2022

Feb 02, 2023

BUY
$1.41 - $2.5 $5,941 - $10,535
4,214 Added 8.74%
52,440 $81,000
Q3 2022

Nov 04, 2022

BUY
$1.66 - $2.79 $9,455 - $15,891
5,696 Added 13.39%
48,226 $83,000
Q2 2022

Aug 01, 2022

SELL
$1.44 - $3.98 $25,934 - $71,679
-18,010 Reduced 29.75%
42,530 $74,000
Q1 2022

May 10, 2022

SELL
$2.97 - $5.2 $42,343 - $74,136
-14,257 Reduced 19.06%
60,540 $217,000
Q4 2021

Feb 08, 2022

BUY
$4.99 - $7.46 $16,776 - $25,080
3,362 Added 4.71%
74,797 $373,000
Q3 2021

Nov 12, 2021

SELL
$7.16 - $9.69 $141,982 - $192,152
-19,830 Reduced 21.73%
71,435 $511,000
Q2 2021

Aug 13, 2021

BUY
$6.23 - $10.03 $82,155 - $132,265
13,187 Added 16.89%
91,265 $846,000
Q1 2021

May 14, 2021

BUY
$8.81 - $16.96 $148,052 - $285,012
16,805 Added 27.43%
78,078 $725,000
Q4 2020

Feb 09, 2021

BUY
$8.5 - $12.85 $127,984 - $193,482
15,057 Added 32.58%
61,273 $542,000
Q3 2020

Nov 13, 2020

BUY
$9.57 - $27.05 $13,866 - $39,195
1,449 Added 3.24%
46,216 $536,000
Q2 2020

Aug 03, 2020

BUY
$7.14 - $31.69 $181,698 - $806,447
25,448 Added 131.73%
44,767 $1.21 Million
Q1 2020

May 15, 2020

SELL
$2.98 - $14.09 $44,327 - $209,588
-14,875 Reduced 43.5%
19,319 $144,000
Q4 2019

Feb 12, 2020

SELL
$1.97 - $3.72 $6,252 - $11,807
-3,174 Reduced 8.49%
34,194 $113,000
Q3 2019

Nov 12, 2019

SELL
$2.05 - $3.02 $971 - $1,431
-474 Reduced 1.25%
37,368 $77,000
Q2 2019

Aug 13, 2019

SELL
$2.29 - $4.1 $9,155 - $16,391
-3,998 Reduced 9.56%
37,842 $111,000
Q1 2019

May 15, 2019

BUY
$3.34 - $5.1 $2,625 - $4,008
786 Added 1.91%
41,840 $156,000
Q4 2018

Feb 14, 2019

SELL
$3.89 - $6.11 $24,911 - $39,128
-6,404 Reduced 13.49%
41,054 $164,000
Q3 2018

Nov 14, 2018

SELL
$3.92 - $5.58 $6,628 - $9,435
-1,691 Reduced 3.44%
47,458 $264,000
Q2 2018

Aug 13, 2018

SELL
$3.88 - $5.16 $11,682 - $15,536
-3,011 Reduced 5.77%
49,149 $193,000
Q1 2018

May 14, 2018

SELL
$4.05 - $5.69 $34,753 - $48,825
-8,581 Reduced 14.13%
52,160 $246,000
Q4 2017

Feb 14, 2018

BUY
$4.13 - $6.68 $17,858 - $28,884
4,324 Added 7.66%
60,741 $251,000
Q3 2017

Nov 13, 2017

BUY
$5.36 - $6.37 $65,166 - $77,446
12,158 Added 27.47%
56,417 $358,000
Q2 2017

Aug 11, 2017

BUY
N/A
44,259
44,259 $347,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $544M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.